Drug Discovery News, Articles, Events

Compounds in coffee may fight Parkinson's
Caffeine plus another compound in coffee beans' waxy coating may protect against brain degeneration...
Phospholipid reactive T-cells could play a role in cancer
Phospholipid-reactive T-cells that are able to recognise phospholipids could help in treatments against cancer, autoimmune diseases and dyslipidemia...
Application Notes supplement 2018
Researchers are always looking more effective and efficient ways of making their work more successful. In this supplement, some of our commercial partners share their data, detailing the application of their technology.
T-cells engineered to recognise tumours expressing the CD30 protein marker
Researchers have genetically engineered immune cells to recognise and fight Hodgkin and non-Hodgkin lymphoma cells...

#soliloquy-container-17517{opacity:1}#soliloquy-container-17517 li>.soliloquy-caption{display:none}#soliloquy-container-17517 li:first-child>.soliloquy-caption{display:block} Compounds in coffee may fight Parkinson's

Compounds in coffee may fight Parkinson's

Phospholipid reactive T-cells could play a role in cancer

T-cells engineered to recognise tumours expressing the CD30 protein marker

Latest news

Application note: Increasing throughput with dual emission AlphaLISA-AlphaPlex assay and simultaneous dual emission detection

Supplement

Application Notes supplement 2018

Event

SLAS Europe 2019 Conference and Exhibition

From our latest issue...

webinar

Integrated fragment-based approach reveals enzymatic inhibitors with potential therapeutic application

Content Hub

Eppendorf

Website development by e-Motive Media Limited.